Sustained and controlled release of lipophilic drugs from a self-assembling amphiphilic peptide hydrogel
Briuglia, Maria Lucia and Urquhart, Andrew and Lamprou, Dimitrios (2014) Sustained and controlled release of lipophilic drugs from a self-assembling amphiphilic peptide hydrogel. International Journal of Pharmaceutics, 474 (1-2). 103–111. ISSN 1873-3476 (https://doi.org/10.1016/j.ijpharm.2014.08.025)
Preview |
PDF.
Filename: BriugliaUrquhartLamprou_IJP2014_sustained_and_controlled_release_of_lipophilic_drugs.pdf
Accepted Author Manuscript Download (792kB)| Preview |
Abstract
Materials which undergo self-assembly to form supermolecular structures can provide alternative strategies to drug loading problems in controlled release application. RADA 16 is a simple and versatile self-assembling peptide with a designed structure formed of two distinct surfaces, one hydrophilic and one hydrophobic that are positioned such a well-ordered fashion allowing precise assembly into a predetermined organization. A “smart” architecture in nanostructures can represent a good opportunity to use RADA16 as a carrier system for hydrophobic drugs solving problems of drugs delivery. In this work, we have investigated the diffusion properties of Pindolol, Quinine and Timolol Maleate from RADA16 in PBS and in BSS-PLUS at 37 °C. A sustained, controlled, reproducible and efficient drug release has been detected for all the systems, which has allow to understand the dependence of release kinetics on the physicochemical characteristics of RADA16 structural and chemical properties of the selected drugs and the nature of solvents used. For the analysis various physicochemical characterization techniques were used in order to investigate the state of the peptide before and after the drugs were added. Not only does RADA16 optimise drug performance, but it can also provide a solution for drug delivery issues associated with lipophilic drugs.
ORCID iDs
Briuglia, Maria Lucia ORCID: https://orcid.org/0000-0002-1737-0767, Urquhart, Andrew and Lamprou, Dimitrios ORCID: https://orcid.org/0000-0002-8740-1661;-
-
Item type: Article ID code: 49139 Dates: DateEvent20 October 2014Published20 August 2014Published Online14 August 2014AcceptedNotes: . “NOTICE: this is the author’s version of a work that was accepted for publication in International Journal of Pharmaceutics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International Journal of Pharmaceutics, [VOL 474, ISSUE 1-2, (20/08/2014)] DOI:10.1016/j.ijpharm.2014.08.025 Subjects: Medicine > Pharmacy and materia medica
Medicine > Therapeutics. PharmacologyDepartment: Faculty of Engineering > Chemical and Process Engineering
Technology and Innovation Centre > Continuous Manufacturing and Crystallisation (CMAC)
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical SciencesDepositing user: Pure Administrator Date deposited: 08 Sep 2014 15:37 Last modified: 20 Nov 2024 01:10 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/49139